Tapayan, Wishney A.
HRN: 21-54-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2022
CEFUROXIME 1.5GM (VIAL)
07/23/2022
07/23/2022
IV
1.5gm
Prior OR
Prophylaxis For Elective Repeat CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes